Despite the antitumour effect of
ursolic acid observed in several
cancers, the underlying mechanism remains unclear. Thus, in the present study, the roles of
AMP-activated protein kinase (AMPK) and
glycogen synthase kinase 3 beta (GSK3β) were examined in
ursolic acid induced apoptosis in HepG2
hepatocellular carcinoma cells.
Ursolic acid significantly exerted cytotoxicity, increased the sub-G1 population and the number of
ethidium homodimer and
terminal deoxynucleotidyl transferase(TdT) mediated dUTP nick end labeling positive cells in HepG2 cells. Also,
ursolic acid enhanced the cleavages of
poly-ADP-ribose polymerase (PARP) and caspase3, attenuated the expression of astrocyte elevated gene (AEG1) and
survivin in HepG2 cells. Interestingly,
ursolic acid increased the phosphorylation of AMPK and
coenzyme A carboxylase and also enhanced phosphorylation of GSK3β at inactive form
serine 9, whereas
ursolic acid attenuated the phosphorylation of AKT and mTOR in HepG2 cells. Conversely,
AMPK inhibitor compound C or GSK3β inhibitor
SB216763 blocked the cleavages of PARP and
caspase 3 induced by
ursolic acid in HepG2 cells. Furthermore, proteosomal inhibitor
MG132 suppressed AMPK activation, GSK3β phosphorylation, cleaved PARP and deceased AEG-1 induced by
ursolic acid in HepG2 cells. Overall, our findings suggest that
ursolic acid induced apoptosis in HepG2 cells via AMPK activation and GSK3β phosphorylation as a potent chemopreventive agent.